Retinitis Pigmentosa Type 11
Showing 1 - 25 of >10,000
Natural History Study of Retinitis Pigmentosa Type 11
Recruiting
- Retinitis Pigmentosa 11
- Retinitis Pigmentosa
- Clinical examinations
-
Oslo, NorwayDepartment of Ophthalmology, Oslo University Hospital
Mar 16, 2021
Retinitis Pigmentosa, Usher Syndrome Type 2 Trial in Canada, France, United States (RNA antisense oligonucleotide for
Terminated
- Retinitis Pigmentosa
- Usher Syndrome Type 2
- RNA antisense oligonucleotide for intravitreal injection
-
Boston, Massachusetts
- +6 more
Dec 12, 2022
X-Linked Retinitis Pigmentosa Trial in Worldwide (Genetic: AAV5-RPGR 4e11, Genetic: AAV5-RPGR 2e11)
Recruiting
- X-Linked Retinitis Pigmentosa
- Genetic: AAV5-RPGR 4e11
- Genetic: AAV5-RPGR 2e11
-
Los Angeles, California
- +9 more
Aug 16, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Usher Syndrome Type 3 Trial in San Francisco (NT-501, Sham)
Completed
- Retinitis Pigmentosa
- +2 more
- NT-501
- Sham
-
San Francisco, CaliforniaUniversity of California, San Francisco
Apr 14, 2022
Usher Syndrome, Retinitis Pigmentosa Trial in Portland, Paris (SAR421869)
Terminated
- Usher Syndrome
- Retinitis Pigmentosa
-
Portland, Oregon
- +1 more
Mar 30, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Dallas, Madison, London (QR-421a, Sham-procedure)
Active, not recruiting
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure
-
Dallas, Texas
- +2 more
Apr 21, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Worldwide (Ultevursen, Sham-procedure)
Recruiting
- Retinitis Pigmentosa
- +7 more
- Ultevursen
- Sham-procedure
-
San Diego, California
- +14 more
Jul 29, 2022
USHer Syndrome (CRUSH) Study
Active, not recruiting
- Usher Syndrome, Type 2A
- +2 more
- No intervention
-
Nijmegen, Gelderland, NetherlandsRadboud universitair medisch centrum
Apr 28, 2022
Rare Disorders, Undiagnosed Disorders, Disorders of Unknown Prevalence Trial in Sioux Falls, Sydney
Recruiting
- Rare Disorders
- +309 more
-
Sioux Falls, South Dakota
- +1 more
Jun 20, 2022
Retinitis Pigmentosa, Usher Syndrome Type 2, Deaf Blind Trial in Canada, France, United States (QR-421a, Sham-procedure (dose
Completed
- Retinitis Pigmentosa
- +7 more
- QR-421a
- Sham-procedure (dose cohort 1&2 only)
-
Boston, Massachusetts
- +6 more
Apr 19, 2022
Natural History of PRPF31 Mutation-Associated Retinal Dystrophy
Recruiting
- Retinitis Pigmentosa
- +4 more
-
San Francisco, California
- +4 more
Oct 5, 2022
Rate of Progression in USH2A-related Retinal Degeneration
Active, not recruiting
- Usher Syndrome, Type 2A
- Retinitis Pigmentosa 39
-
San Francisco, California
- +15 more
Mar 8, 2022
X-Linked Retinitis Pigmentosa
Completed
- X-Linked Retinitis Pigmentosa
- Other: Assessments
-
Phoenix, Arizona
- +21 more
Jan 17, 2023
Retinitis Pigmentosa, Retinitis, Retinal Diseases Trial in Puerto Rico, United States (Gene Therapy Product-vMCO-010, Sham
Active, not recruiting
- Retinitis Pigmentosa
- +6 more
- Gene Therapy Product-vMCO-010
- Sham Injection
-
Beverly Hills, California
- +6 more
Jul 13, 2022
Glaucoma, Age-related Macular Degeneration, Retinitis Pigmentosa Trial in Guangzhou (New head-mounted visual aids)
Not yet recruiting
- Glaucoma
- +3 more
- New head-mounted visual aids
-
Guangzhou, Guangdong, ChinaZhongshan Ophthalmic Center, Sun Yat-sen University
Oct 7, 2023
Patients With X-linked Retinitis Pigmentosa (XLRP)
Completed
- X-Linked Retinitis Pigmentosa
-
Durham, North Carolina
- +2 more
Jan 10, 2023
Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)
Completed
- Retinitis Pigmentosa
- Wharton's jelly derived mesenchymal stemcells
- Magnovision
-
Ankara, Gölbaşı, Turkey
- +2 more
Mar 23, 2023
Retinitis Pigmentosa Trial in Worldwide (N-acetylcysteine, Placebo)
Not yet recruiting
- Retinitis Pigmentosa
- N-acetylcysteine
- Placebo
-
Davis, California
- +30 more
Sep 8, 2022
Age-Related Macular Degeneration, Retinitis Pigmentosa, Ultrasound Therapy; Complications Trial (Non-invasive ultrasound retinal
Not yet recruiting
- Age-Related Macular Degeneration
- +2 more
- Non-invasive ultrasound retinal stimulation Device
- (no location specified)
Jun 19, 2023
Retinitis Pigmentosa Trial (Subtenon injection of Wharton jelly derived mesenchymal stem cells, Subtenon injection of Wharton
Recruiting
- Retinitis Pigmentosa
- Subtenon injection of Wharton jelly derived mesenchymal stem cells
- +2 more
-
Kayseri, TurkeyErciyes University, Faculty of Medicine
Sep 5, 2022
Non-syndromic Retinitis Pigmentosa Trial in Pittsburgh, Paris, London (Gene therapy: GS030-DP AND Medical device: GS030-MD)
Recruiting
- Non-syndromic Retinitis Pigmentosa
- Gene therapy: GS030-DP AND Medical device: GS030-MD
-
Pittsburgh, Pennsylvania
- +2 more
Jul 25, 2022
Macular Edema, Inherited Retinal Dystrophy, Laser Retinopathy Trial in Rome (subthreshold treatment with micropulsed laser)
Not yet recruiting
- Macular Edema
- +2 more
- subthreshold treatment with micropulsed laser
-
Rome, RM, ItalyIRCSS Fondazione G:B:Bietti
Jul 27, 2023
Advanced Retinitis Pigmentosa Trial in United States (RST-001)
Active, not recruiting
- Advanced Retinitis Pigmentosa
-
San Francisco, California
- +3 more
Sep 9, 2022
X-linked Retinal Dystrophy Associated With Mutations in
Recruiting
- Retinitis Pigmentosa
-
La Jolla, California
- +7 more
Apr 5, 2022